Literature DB >> 5104496

Pharmacological differentiation of "nicotinic" and "muscarinic" catalepsy.

G Zetler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5104496     DOI： 10.1016/0028-3908(71)90052-9

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN： 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  7 in total

1.  Evidence for a cholinergic role in haloperidol-induced catalepsy.

Authors:  W R Klemm
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

2.  Experimental catalepsy: influences of cholinergic transmission in restraint-induced catalepsy.

Authors:  W R Klemm
Journal:  Experientia       Date:  1983-02-15

3.  Cholinergic-dopaminergic interactions in experimental catalepsy.

Authors:  W R Klemm
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.

Authors:  K Onodera; H Shinoda
Journal:  Agents Actions       Date:  1991-05

5.  Discriminative stimulus properties of arecoline: a new approach for studying central muscarinic receptors.

Authors:  L T Meltzer; J A Rosecrans
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

6.  Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.

Authors:  L Ahtee; S Kaakkola
Journal:  Br J Pharmacol       Date:  1978-02       Impact factor: 8.739

7.  Experimental catalepsy is both enhanced and disrupted by apomorphine.

Authors:  W R Klemm
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.